Posted in Clinical Data ACC 2026: sotatercept meta-analysis backs disease-modifying role in PAH April 2, 2026 Pharmaceutical Technology New data presented at ACC 2026 clarifies sotatercept’s role alongside vasodilator-based regimens in PAH patients. Clinical DataCardiovascularRead full story